A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression
Weiyi Yu Xianying Chen Qiubing Chen Peixuan Chen Naizhang Liu Yingjian Li Xue Tan Qiuhan Zhang Yan Rao Ming Guo Zhixiang Huang Xin Wang Zhen ZhangWenjie Xiang Yuzhen Zhang Qianyun Liu Hao Yin Li Zhou Yu Chen Ke Lan
A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression
摘要
关键词
SARS-CoV-2/mRNA vaccine/Lipid nanoparticles分类
医药卫生引用本文复制引用
Weiyi Yu,Xianying Chen,Qiubing Chen,Peixuan Chen,Naizhang Liu,Yingjian Li,Xue Tan,Qiuhan Zhang,Yan Rao,Ming Guo,Zhixiang Huang,Xin Wang,Zhen ZhangWenjie Xiang,Yuzhen Zhang,Qianyun Liu,Hao Yin,Li Zhou,Yu Chen,Ke Lan..A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression[J].Virologica Sinica,2025,40(5):P.793-803,11.基金项目
supported by the National Key R&D Program of China(2021YFF0702000 to Y.Chen,2021YFC2300700 to L.Zhou) (2021YFF0702000 to Y.Chen,2021YFC2300700 to L.Zhou)
the National Natural Science Foundation of China(grants 82341061,82172243 and 82372223 to Y.Chen) (grants 82341061,82172243 and 82372223 to Y.Chen)
the Fundamental Research Funds for the Central Universities(2042022dx0003 to Y.Chen) (2042022dx0003 to Y.Chen)
the Hubei Provincial Natural Science Foundation(2023AFB201 to Z.Zhang,and 2024AFB906 to L.Zhou.) (2023AFB201 to Z.Zhang,and 2024AFB906 to L.Zhou.)
the China Postdoctoral Science Foundation(2023M732705 to Q.Liu). (2023M732705 to Q.Liu)